We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

126 hedge funds and large institutions have $349M invested in Spectrum Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

47% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 34

6% more funds holding

Funds holding: 119126 (+7)

2% more capital invested

Capital invested by funds: $341M → $349M (+$8.35M)

21% less call options, than puts

Call options by funds: $1.86M | Put options by funds: $2.35M

Holders
126
Holders Change
+7
Holders Change %
+5.88%
% of All Funds
3.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
50
Reduced
34
Closed
8
Calls
$1.86M
Puts
$2.35M
Net Calls
-$483K
Net Calls Change
+$1.34M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$38.2M -$68.6K -9,035 -0.2%
BFA
2
BlackRock Fund Advisors
California
$37.5M +$4.52M +596,356 +15%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$34.5M -$2.62M -345,000 -8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$30.5M +$251K +33,125 +0.9%
State Street
5
State Street
Massachusetts
$22.6M -$4.42M -582,689 -17%
BIT
6
BlackRock Institutional Trust
California
$15.6M +$618K +81,483 +4%
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$12.2M +$9.68M +1,275,291 +568%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$10.1M -$46.1K -6,075 -0.5%
Goldman Sachs
9
Goldman Sachs
New York
$9.95M -$1.23M -162,452 -12%
RCAMU
10
Rothschild & Co Asset Management US
Connecticut
$9.05M +$1.03M +136,230 +14%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$8.47M +$165K +21,693 +2%
Barclays
12
Barclays
United Kingdom
$8.28M +$85.7K +11,298 +1%
Federated Hermes
13
Federated Hermes
Pennsylvania
$8.15M -$211K -27,785 -3%
Wellington Management Group
14
Wellington Management Group
Massachusetts
$7.34M +$292K +38,430 +4%
KCM
15
Kennedy Capital Management
Missouri
$6.94M -$706K -93,095 -10%
ACM
16
Ashford Capital Management
Delaware
$6.26M +$1.69M +223,116 +41%
Northern Trust
17
Northern Trust
Illinois
$6.1M -$777K -102,419 -12%
JAM
18
Jupiter Asset Management
United Kingdom
$5.11M +$561K +73,900 +13%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$4.59M +$73.3K +9,659 +2%
FLAM
20
First Light Asset Management
Minnesota
$2.99M +$141K +18,623 +5%
Deutsche Bank
21
Deutsche Bank
Germany
$2.95M +$613K +80,731 +29%
Principal Financial Group
22
Principal Financial Group
Iowa
$2.9M +$57.2K +7,534 +2%
PAM
23
Panagora Asset Management
Massachusetts
$2.86M +$1.16M +153,062 +77%
Macquarie Group
24
Macquarie Group
Australia
$2.58M +$286K +37,635 +13%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$2.37M +$46.1K +6,079 +2%

SPPI Hedge Fund Activity: Q2 2014 in Review

126 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2014, worth a combined $349M — up 2.4% from $341M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new SPPI positions and 8 closed out — a net gain of 8 holders — while 50 added to existing stakes and 34 trimmed.

The largest buyer was Bank of Montreal, adding an estimated $9.68M. The largest seller was Deerfield Management, cutting an estimated $8.39M.

  • 126 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2014, up from 119 in Q1 2014.
  • Funds reported $349M of Spectrum Pharmaceuticals Inc stock for Q2 2014, up 2.4% quarter-over-quarter.
  • 16 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2014 and 8 closed out, a net change of +8 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2014 was Bank of Montreal, an estimated $9.68M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2014 was Deerfield Management, an estimated $8.39M sold.

Based on aggregated 13F filings for Q2 2014.